
3) close contact with someone with SARS-CoV-2 infection (for patients and visitors) or a higher-risk exposure (for healthcare personnel (HCP).1) a positive viral test for SARS-CoV-2.Establish a process to make everyone entering the facility aware of recommended actions to prevent transmission to others if they have any of the following three criteria:.Dating these alerts can help ensure people know that they reflect current recommendations. These alerts should include instructions about current IPC recommendations (e.g., when to use source control and perform hand hygiene). Post visual alerts (e.g., signs, posters) at the entrance and in strategic places (e.g., waiting areas, elevators, cafeterias).Ensure everyone is aware of recommended IPC practices in the facility.HCP, patients, and visitors should be offered resources and counseled about the importance of receiving the COVID-19 vaccine.Įstablish a Process to Identify and Manage Individuals with Suspected or Confirmed SARS-CoV-2 Infection.Recommended routine infection prevention and control (IPC) practices during the COVID-19 pandemicĮncourage everyone to remain up to date with all recommended COVID-19 vaccine doses.

CDC’s main landing page for COVID-19 content will help readers navigate to information regarding modes of transmission, clinical management, laboratory settings, COVID-19 vaccines and CDC guidance on other COVID-19-related topics.Įmployers should be aware that other local, territorial, tribal, state, and federal requirements may apply, including those promulgated by the Occupational Safety and Health Administration (OSHA).ġ. This guidance is not intended for non-healthcare settings (e.g., restaurants) and not for persons outside of healthcare settings. settings where healthcare is delivered (including nursing homes and home health). This guidance provides a framework for facilities to implement select infection prevention and control practices (e.g., universal source control) based on their individual circumstances (e.g., levels of respiratory virus transmission in the community). Updates were made to reflect the high levels of vaccine-and infection-induced immunity and the availability of effective treatments and prevention tools. This interim guidance has been updated based on currently available information about COVID-19 and the current situation in the United States.
